A quasi-experimental study examining a nurse-led educational program to improve disease knowledge and self-care for patients with acute decompensated heart failure with reduced ejection fraction
Abstract:A quasiexperimental study examining a nurse-led educational program to improve disease knowledge and self-care for patients with acute decompensated heart failure with reduced ejection fraction [published online as ahead of print on December 2, 2021].
“…The paper by Kolasa et al pointed out that during 3 months' post-discharge follow-up, optimization of heart failure therapy was conducted at 16% of primary care physician appointments and at 30% of outpatient cardiologist appointments [27], although the recommendations in force between 2016 and 2021 emphasized the need for rapid treatment optimization for patients with HFrEF to improve their prognosis [28], and the current recommendations also state the need for rapid, simultaneous optimization of treatment with the four drug classes that improve the prognosis for patients with HFrEF [5]. The use of HFrEF-modifying therapy at recommended doses, compared with lower doses, allows for more effective reduction in the risk of death and heart failure hospitalization in patients with HFrEF [29].…”
Drugs introduced into clinical practice have rarely been tested in national populations. It is generally assumed that the results of pivotal studies are the same in different populations. Due to the considerable population of patients in the TRANSITION study recruited at Polish sites, a post-hoc analysis was feasible to compare the efficacy and safety of sacubitril/valsartan in the group of Polish patients with patients recruited at other sites. This analysis provides additional information both on patient characteristics and efficacy and safety of early sacubitril/valsartan initiation after an acute heart failure episode in the population of Polish patients with HFrEF. To the best of our knowledge, the only comparison of Polish patients with patients from other countries participating in the Heart Failure Pilot Survey (ESC-HF Pilot) was published in 2013. In addition, it is one of the few analyses concerning the Polish experience with the use of this modern treatment.
“…The paper by Kolasa et al pointed out that during 3 months' post-discharge follow-up, optimization of heart failure therapy was conducted at 16% of primary care physician appointments and at 30% of outpatient cardiologist appointments [27], although the recommendations in force between 2016 and 2021 emphasized the need for rapid treatment optimization for patients with HFrEF to improve their prognosis [28], and the current recommendations also state the need for rapid, simultaneous optimization of treatment with the four drug classes that improve the prognosis for patients with HFrEF [5]. The use of HFrEF-modifying therapy at recommended doses, compared with lower doses, allows for more effective reduction in the risk of death and heart failure hospitalization in patients with HFrEF [29].…”
Drugs introduced into clinical practice have rarely been tested in national populations. It is generally assumed that the results of pivotal studies are the same in different populations. Due to the considerable population of patients in the TRANSITION study recruited at Polish sites, a post-hoc analysis was feasible to compare the efficacy and safety of sacubitril/valsartan in the group of Polish patients with patients recruited at other sites. This analysis provides additional information both on patient characteristics and efficacy and safety of early sacubitril/valsartan initiation after an acute heart failure episode in the population of Polish patients with HFrEF. To the best of our knowledge, the only comparison of Polish patients with patients from other countries participating in the Heart Failure Pilot Survey (ESC-HF Pilot) was published in 2013. In addition, it is one of the few analyses concerning the Polish experience with the use of this modern treatment.
“…Percezione e gestione della salute -Comprendere la causa della loro HF, i sintomi e la scelta del trattamento. [11,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33] -Comprendere la prognosi e le diverse possibili fasi della traiettoria HF.…”
Section: Modelli Funzionali Topic Educativo Per L'assistitounclassified
“…Nutrizionale metabolico -Essere in grado di evitare l'assunzione di grandi volumi di liquidi. [13,15,18,19,20,21,22,24,26,27,28,32,33] -Essere in grado di prevenire la malnutrizione e saper mangiare sano, evitando l'assunzione eccessiva di sale (>5 g/giorno) e mantenendo e monitorando un peso corporeo sano.…”
Section: Modelli Funzionali Topic Educativo Per L'assistitounclassified
“…[15] Attività ed esercizio fisico -Intraprendere un regolare esercizio fisico ed essere fisicamente attivi. [15,20,21,22,24,26,27,30,33,34,35] -Adattare l'attività fisica allo stato dei sintomi e alle circostanze personali (depressione).…”
Section: Modelli Funzionali Topic Educativo Per L'assistitounclassified
Introduzione: lo scompenso cardiaco porta ad alti tassi di riammissione ospedaliera: quasi il 60% dei soggetti dimessi viene re-ospedalizzato entro un anno dal primo ricovero. L’educazione alla gestione della patologia alla dimissione diventa essenziale per prevenire questo fenomeno.
Obiettivi: descrivere i topic educativi, secondo i Modelli Funzionali di Gordon, da includere nell’intervento educativo, al fine di prevenire la riammissione in ospedale dell’assistito con scompenso cardiaco.
Materiali e Metodi: è stata condotta una revisione narrativa della letteratura consultando le banche dati MEDLINE e CINHAL.
Risultati: sono stati inclusi 28 articoli nella revisione. Dall’analisi dei materiali rispetto ai Modelli Funzionali, la letteratura reperita ne indaga 9 su 11. I modelli che non vengono attenzionati dall’educazione alla dimissione risultano Sessualità e Riproduzione e Valori e Convinzioni. Inoltre, la letteratura ha sottolineato come un processo educativo personalizzato alla dimissione sia utile nel prevenire le riammissioni ospedaliere per riacutizzazione della patologia.
Conclusioni: l’educazione terapeutica organizzata secondo i Modelli di Gordon, potrebbe migliorare l’efficacia dell’intervento nella prevenzione delle riammissioni per scompenso cardiaco. Il fatto di includere tutti gli aspetti della persona migliora la qualità di vita e permette un’efficace convivenza con la malattia.
“…Examples of papers adhering to respective checklists, published in Advances in Clinical and Experimental Medicine in 2021 and 2022[46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65] …”
Various guidelines for authors of research papers and the checklists that often accompany these statements play an important role in the creation of carefully written scientific papers -for authors, they serve as tools to ensure the correct structure and content of the manuscript, increasing the chances that a paper will be published in a journal with a high rejection rate. The aim of this editorial is to provide a concise outline of the checklists most frequently used to guide the structuring of papers published in Advances in Clinical and Experimental Medicine, and to support current and prospective authors of this journal in choosing a checklist for their manuscript.The EQUATOR website is presented as a useful tool in choosing a checklist: https://www.equator-network.org/. Then, 8 checklists that are most popular among authors who publish their work in Advances in Clinical and Experimental Medicine are outlined: STROBE -for observational studies; ARRIVE -for any area of bioscience research using laboratory animals; CASP -for qualitative studies; CONSORT -for parallel group randomized trials; PRISMA -for all reviews and meta-analyses; SQUIRE -for studies on quality improvement in healthcare; STARD -for diagnostic accuracy studies; REMARK -for tumor marker prognostic studies. Each of the 8 presented checklists is discussed in a following order: 1) the name of the checklist is explained; 2) the type of articles to which it is intended is pointed out; 3) the structure of the checklist is explained; 4) if there are any extensions of the presented checklist for specific subtypes of papers, they are listed; 5) the most important literature on the presented checklist is provided.As a take-home message, basic tips for choosing a checklist are formulated. Finally, examples of papers adhering to each discussed checklist are provided.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.